Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sake J. van der Wall"'
Autor:
Sake J. van der Wall, Christine Teutsch, Sergio J. Dubner, Hans-Christoph Diener, Jonathan L. Halperin, Chang Sheng Ma, Kenneth J. Rothman, Miney Paquette, Kristina Zint, Lionel Riou França, Shihai Lu, Gregory Y. H. Lip, Menno V. Huisman
Publikováno v:
TH Open, Vol 05, Iss 01, Pp e35-e42 (2021)
Objective Anticoagulation management in patients with atrial fibrillation (AF) and impaired renal function is challenging. This study aimed to evaluate anticoagulation prescription patterns in relation to renal function and to describe 2-year clinica
Externí odkaz:
https://doaj.org/article/fe4f963d8c3145c5988f99f3efdf9830
Autor:
Sake J. van der Wall, Liselotte M. van der Pol, Yvonne M. Ende-Verhaar, Suzanne C. Cannegieter, Sam Schulman, Paolo Prandoni, Marc Rodger, Menno V. Huisman, Frederikus A. Klok
Publikováno v:
European Respiratory Review, Vol 27, Iss 150 (2018)
Current guidelines recommend long-term anticoagulant therapy in patients with unprovoked venous thromboembolism (VTE). The risk of fatal recurrent VTE after treatment discontinuation (versus that of fatal bleeding during anticoagulation) is of partic
Externí odkaz:
https://doaj.org/article/d74271e5f46147859f2b4002a8e6b590
Autor:
Sake J. van der Wall, Frederikus A. Klok, Paul L. den Exter, Deisy Barrios, Raquel Morillo, Suzanne C. Cannegieter, David Jimenez, Menno V. Huisman
Publikováno v:
HemaSphere, Vol 2, Iss 1 (2018)
Abstract. Current guidelines recommend low-molecular-weight-heparins (LMWH) monotherapy for 3 to 6 months as first-line treatment for cancer-associated venous thromboembolism (VTE). In clinical practice, enoxaparin and nadroparin are common agents us
Externí odkaz:
https://doaj.org/article/6fbdb87a43194a6bb8b8155af0dc6867
Autor:
Chang Sheng Ma, Jonathan L. Halperin, Hans-Christoph Diener, Christine Teutsch, Kristina Zint, Menno V. Huisman, Kenneth J. Rothman, Gregory Y.H. Lip, Sake J van der Wall, Christian Hall, Sergio Dubner, Gloria-Af Investigators, Oskars Kalejs, Dongmei Zhai, Philippe Lyrer
Publikováno v:
van der Wall, S J, Lip, G Y H, Teutsch, C, Kalejs, O, Lyrer, P, Hall, C, Dubner, S J, Diener, H-C, Halperin, J L, Ma, C S, Rothman, K J, Zint, K, Zhai, D, Huisman, M V & GLORIA-AF Investigators 2021, ' Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions : the GLORIA-AF study ', European Journal of Internal Medicine, vol. 91, pp. 75-80 . https://doi.org/10.1016/j.ejim.2021.05.020
European Journal of Internal Medicine, 91, 75-80. ELSEVIER
European Journal of Internal Medicine, 91, 75-80. ELSEVIER
BACKGROUND: Prospective data on nonvitamin-K-antagonist oral anticoagulant (NOAC) management during cardiovascular interventions are limited. We therefore evaluated the safety and effectiveness of uninterrupted dabigatran therapy as well as dabigatra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a032f48e5b04466042a28c931b3c037b
https://doi.org/10.1016/j.ejim.2021.05.020
https://doi.org/10.1016/j.ejim.2021.05.020
Autor:
John W. Eikelboom, Richard P. Whitlock, Sake J van der Wall, Iqbal H. Jaffer, Saurabh Gupta, Emilie P. Belley-Côté, Kevin R An, Kevin J. Um, Graham R. McClure, Arjun Pandey, Jessica Spence
Publikováno v:
Thrombosis and Haemostasis. 119:328-339
Background The optimal antithrombotic therapy after surgical bioprosthetic aortic valve replacement (BAVR) is uncertain. We conducted a systematic review and meta-analysis of observational studies and randomized controlled trials (RCTs) comparing ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc84f8ef2f10bac14c70e36ca0f975de
https://doi.org/10.1055/s-0038-1676816
https://doi.org/10.1055/s-0038-1676816
Autor:
Menno V. Huisman, Nienke van Rein, Frederikus A. Klok, Peter E. Westerweel, A. Marco Alings, T.A. Simmers, Robert G. Tieleman, Karina Meijer, Sake J van der Wall, Bart J F van den Bemt, Marieke J. H. A. Kruip, Liane C J te Boome
Publikováno v:
Europace, 21(3), 414-420. Oxford University Press
Europace, 21, 3, pp. 414-420
EP-Europace
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(3), 414. Oxford University Press
Europace, 21, 414-420
EP-Europace, 21(3), 414-420. OXFORD UNIV PRESS
Europace, 21, 3, pp. 414-420
EP-Europace
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(3), 414. Oxford University Press
Europace, 21, 414-420
EP-Europace, 21(3), 414-420. OXFORD UNIV PRESS
Item does not contain fulltext AIMS: Because practice-based data on the usage of idarucizumab for urgent dabigatran reversal is unavailable, we evaluated the appropriateness of idarucizumab usage, its haemostatic effectiveness and clinical outcomes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::250506f1f15d89271439e2f0ce977cdc
https://doi.org/10.1093/europace/euy220
https://doi.org/10.1093/europace/euy220
Autor:
Frederikus A. Klok, Sake J van der Wall, Menno V. Huisman, Gordon Chu, Stefano Barco, Stavros Konstantinides, Luca Valerio
Publikováno v:
Heart, 107(7), 549-555. BMJ PUBLISHING GROUP
ObjectivesCurrent international guidelines advocate the application of bleeding risk scores only to identify modifiable risk factors, but not to withhold treatment in patients at high risk of bleeding. VTE-BLEED (ActiVe cancer, male with uncontrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd95c29601d4999cb39ac25428e54c57
https://hdl.handle.net/1887/3230167
https://hdl.handle.net/1887/3230167
Autor:
Gregory Y.H. Lip, Hans-Christoph Diener, Miney Paquette, Kristina Zint, Shihai Lu, Christine Teutsch, Lionel Riou França, Chang Sheng Ma, Kenneth J. Rothman, Menno V. Huisman, Sake J van der Wall, Jonathan L. Halperin, Sergio Dubner
Publikováno v:
van der Wall, S J, Teutsch, C, Dubner, S J, Diener, H-C, Halperin, J L, Ma, C S, Rothman, K J, Paquette, M, Zint, K, França, L R, Lu, S, Lip, G Y H, Huisman, M V & GLORIA-AF Investigators 2021, ' Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation : Results from GLORIA-AF ', TH Open, vol. 5, no. 1, pp. e35-e42 . https://doi.org/10.1055/s-0040-1722706
TH Open: Companion Journal to Thrombosis and Haemostasis
TH Open, Vol 05, Iss 01, Pp e35-e42 (2021)
TH Open: Companion Journal to Thrombosis and Haemostasis
TH Open, Vol 05, Iss 01, Pp e35-e42 (2021)
Objective Anticoagulation management in patients with atrial fibrillation (AF) and impaired renal function is challenging. This study aimed to evaluate anticoagulation prescription patterns in relation to renal function and to describe 2-year clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::016b5904c4e5364e768da7cf4cadcfe1
https://vbn.aau.dk/da/publications/cb3dd921-3f97-45a4-b75e-7c3a225ca2ab
https://vbn.aau.dk/da/publications/cb3dd921-3f97-45a4-b75e-7c3a225ca2ab
Autor:
Frederikus A. Klok, Joanne van Ryn, Paul A. Reilly, Amelie Elsaesser, James Aisenberg, Sake J van der Wall, Renato D. Lopes, Stephan Glund, Charles V. Pollack, Menno V. Huisman
Publikováno v:
Circulation, 139(6), 748-756
Background: Although dabigatran has a favorable risk-benefit profile compared with vitamin K antagonist therapy for venous thromboembolism and nonvalvular atrial fibrillation, major bleeding events, including gastrointestinal (GI) bleeding, may occur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4275ab7cbd73b19945c4f3d067fd01b
http://hdl.handle.net/1887/119556
http://hdl.handle.net/1887/119556
Autor:
Menno V. Huisman, Suzanne C. Cannegieter, Yvonne M. Ende-Verhaar, Marc A. Rodger, Liselotte M. van der Pol, Sake J van der Wall, Paolo Prandoni, Frederikus A. Klok, Sam Schulman
Publikováno v:
European Respiratory Review, 27(150)
van der Wall, S J, van der Pol, L M, Ende-Verhaar, Y M, Cannegieter, S C, Schulman, S, Prandoni, P, Rodger, M, Huisman, M V & Klok, F A 2018, ' Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review ', European respiratory review : an official journal of the European Respiratory Society, vol. 27, no. 150 . https://doi.org/10.1183/16000617.0094-2018
European Respiratory Review, Vol 27, Iss 150 (2018)
van der Wall, S J, van der Pol, L M, Ende-Verhaar, Y M, Cannegieter, S C, Schulman, S, Prandoni, P, Rodger, M, Huisman, M V & Klok, F A 2018, ' Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review ', European respiratory review : an official journal of the European Respiratory Society, vol. 27, no. 150 . https://doi.org/10.1183/16000617.0094-2018
European Respiratory Review, Vol 27, Iss 150 (2018)
Current guidelines recommend long-term anticoagulant therapy in patients with unprovoked venous thromboembolism (VTE). The risk of fatal recurrent VTE after treatment discontinuation (versus that of fatal bleeding during anticoagulation) is of partic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f53b90a7f76312f92763536dcf0fbecf
http://hdl.handle.net/1887/119571
http://hdl.handle.net/1887/119571